
AIChemy is an AI-driven drug discovery company that aims to revolutionize early-stage small molecule drug discovery. Their platform, AÍChemy, uses a proprietary Scientific AI engine, specifically an equivariant deep probabilistic graph neural network incorporating geometry, biology, physics, and quantum chemistry. This technology allows for faster, cheaper, and more sustainable drug discovery by accurately predicting the efficacy and safety of potential drug candidates. The platform offers unmatched accuracy, outperforming standard tools like Qvina-W, and provides uncertainty estimates for all predictions. AIChemy collaborates with pharmaceutical and biotech companies, offering a SaaS platform that is customizable and aims to democratize access to treatments for rare diseases.

AIChemy is an AI-driven drug discovery company that aims to revolutionize early-stage small molecule drug discovery. Their platform, AÍChemy, uses a proprietary Scientific AI engine, specifically an equivariant deep probabilistic graph neural network incorporating geometry, biology, physics, and quantum chemistry. This technology allows for faster, cheaper, and more sustainable drug discovery by accurately predicting the efficacy and safety of potential drug candidates. The platform offers unmatched accuracy, outperforming standard tools like Qvina-W, and provides uncertainty estimates for all predictions. AIChemy collaborates with pharmaceutical and biotech companies, offering a SaaS platform that is customizable and aims to democratize access to treatments for rare diseases.